MeSH Browser

MeSH Heading: Carbidopa
Tree Number(s): D02.092.311.200.538.200; D02.442.200; D02.455.426.559.389.657.166.175.200.538.200
Unique ID: D002230
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D002230
Scope Note: An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself.
Entry Term(s): Carbidopa, (R)-Isomer; Carbidopa, (S)-Isomer; Lodosin; Lodosyn; MK-485; MK-486; Methyldopahydrazine
Pharm Action: Antiparkinson Agents
Dopamine Agents
Aromatic Amino Acid Decarboxylase Inhibitors
Related Numbers: 28860-95-9; 28875-92-5; 38821-49-7
CAS Type 1 Name: Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)-
Previous Indexing: Dopa (1972-1974); Hydrazines (1972-1974); Methyldopa (1972-1974)
Public MeSH Note: 80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79
Online Note: use CARBIDOPA to search METHYLDOPAHYDRAZINE 1973-79 (as Prov 1973-74)
History Note: 80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79; was METHYLDOPAHYDRAZINE 1973-74 (Prov)
Date Established: 1980/01/01
Date of Entry: 1999/01/01
Revision Date: 2018/06/19

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Carbidopa MeSH Descriptor Data 2024